Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-03-20 5:23 pm Purchase | 13D | Aurinia Pharmaceuticals Inc. AUPH | ILJIN SNT Co. Ltd. | 7,539,891 13.000% | 355,993 (+4.96%) | View |
| 2023-05-10 4:30 pm Unchanged | 13D | Aurinia Pharmaceuticals Inc. AUPH | ILJIN SNT Co. Ltd. | 7,183,898 13.000% | 0 (Unchanged) | View |
| 2023-01-20 4:30 pm Unchanged | 13D | Aurinia Pharmaceuticals Inc. AUPH | ILJIN SNT Co. Ltd. | 7,183,898 13.000% | 0 (Unchanged) | View |
| 2023-01-06 4:30 pm Sale | 13D | Aurinia Pharmaceuticals Inc. AUPH | ILJIN SNT Co. Ltd. | 7,183,898 13.000% | -1,093,902 (-13.21%) | View |
| 2022-03-03 4:15 pm Sale | 13D | Aurinia Pharmaceuticals Inc. AUPH | ILJIN SNT Co. Ltd. | 8,277,800 13.000% | -717,639 (-7.98%) | View |
| 2021-01-27 4:14 pm Sale | 13D | Aurinia Pharmaceuticals Inc. AUPH | ILJIN SNT Co. Ltd. | 8,995,439 7.100% | -1,536,675 (-14.59%) | View |
| 2021-01-26 4:06 pm Sale | 13D | Aurinia Pharmaceuticals Inc. AUPH | ILJIN SNT Co. Ltd. | 10,532,114 8.300% | -1,237,922 (-10.52%) | View |
| 2020-10-09 4:05 pm Sale | 13D | Aurinia Pharmaceuticals Inc. AUPH | ILJIN SNT Co. Ltd. | 11,770,036 9.300% | -631,491 (-5.09%) | View |
| 2020-07-23 4:52 pm Sale | 13D | Aurinia Pharmaceuticals Inc. AUPH | ILJIN SNT Co. Ltd. | 12,401,527 10.900% | -1,308,252 (-9.54%) | View |